Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
This study aims to investigate the impact of medications containing the active ingredients hydroxychloroquine and favipiravir on the auditory system, as well as to examine the effect of COVID-19 on hearing and its potential relationship with medication use and COVID-19 vaccine dose.
Study Type
OBSERVATIONAL
Enrollment
90
Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated.
Biruni University
Istanbul, Turkey (Türkiye)
Pure tone and high frequency hearing thresholds
Time frame: December, 2021-February 2022
Transient evoked otoacoustic emissions - Signal/noise ratio
Time frame: December, 2021-February 2022
Distortion product otoacoustic emissions- signal/noise ratio
Time frame: December, 2021-February 2022
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.